EDMONTON, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) — Melcor Developments Ltd. (“Melcor”) (TSX: MRD), an Alberta-based real estate development and asset management company, today reported results for the third quarter ended September 30, 2025. The third quarter Management Discussion & Analysis (MD&A) and Condensed Interim Financial Statements are available on our website (www.melcor.ca) under Investors, or on SEDAR+ (www.sedarplus.ca). Timothy Melton, Melcor’s Executive Chair and Chief Executive Officer, commented: “Melcor is pleased to report results for the third quarter of 2025. Revenue in the quarter was up 21.9% to $72.54 million (Q3-2024: $59.51 million) and year-to-date revenues are up 24.8% to $223.43 million (2024: $178.96 million). Funds from operations were also up 41.8% to $23.40 million (Q3-2024:...

CALGARY, Alberta, Nov. 06, 2025 (GLOBE NEWSWIRE) — Maxim Power Corp. (“MAXIM” or the “Corporation”) (TSX: MXG) announced today the release of financial and operating results for the third quarter ended September 30, 2025. The unaudited condensed consolidated interim financial statements, accompanying notes and Management’s Discussion and Analysis (“MD&A”) will be available on SEDAR+ and on MAXIM’s website on November 6, 2025. All figures reported herein are Canadian dollars unless otherwise stated. FINANCIAL HIGHLIGHTS  Three Months EndedSeptember 30, Nine Months EndedSeptember 30,($ in thousands except per share amounts) 2025   2024   2025   2024  Revenue 27,228   25,659   68,907   77,434  Net income 10,620   10,744   14,272   22,287  Earnings per share – basic 0.17   0.21   0.22   0.44  Earnings...

VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) — Glacier Media Inc. (TSX: GVC) (“Glacier” or the “Company”) reported revenue and earnings for the period ended September 30, 2025. Summary Results(thousands of dollars)   Three months ended September 30,   Nine months ended September 30,except share and per share amounts     2025       2024       2025       2024                   Revenue   $ 40,263     $ 40,239     $ 105,362     $ 108,521  EBITDA(1)   $ 6,518     $ 5,867     $ 4,841     $ 6,452  EBITDA(1)margin     16.2 %     14.6 %     4.6 %     5.9 %EBITDA(1)per share   $ 0.05     $ 0.04     $ 0.04     $ 0.05  Capital expenditures   $ 899     $ 954     $ 3,673     $ 2,942  Net (loss) income attributable to common shareholder   $ 6,742     $ 37     $ (2,765 )   $ (7,672 )Net (loss) income...

ROUGEMONT, Quebec, Nov. 06, 2025 (GLOBE NEWSWIRE) — Lassonde Industries Inc. (TSX: LAS.A) (“Lassonde” or the “Corporation”) today announced its financial results for the third quarter of 2025. Financial Highlights:  Third quarters endedSept. 27, 2025 Sept. 28, 2024 ∆(in millions of dollars, unless otherwise indicated) $ $ $Sales 723.9 668.3   55.6Gross profit 197.6 179.8   17.8Operating profit 57.9 47.2   10.7Profit 37.0 29.1   7.9Attributable to:Corporation’s shareholders 36.8 29.7   7.1Non-controlling interests 0.2 (0.6 ) 0.8EPS (in $) 5.40 4.35   1.05Weighted average number of shares outstanding (in thousands) 6,822 6,822   –Adjusted EBITDA1 86.4 69.3   17.1Adjusted EPS1 (in $) 5.84 4.53   1.31Note: These are financial highlights only. Management’s Discussion and Analysis, the...

THE WOODLANDS, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today reported operational and financial results for the third quarter of 2025 and updated guidance for the remainder of the year. Third Quarter 2025 HighlightsSold 13,332 barrels of oil per day (“Bo/d”), near the mid-point of guidance and 20,789 barrels of oil equivalent per day (“Boe/d”) which was above the mid-point of guidance; Reported a net loss of $51.6 million, or $(0.25) per diluted share, which includes $72.9 million of non-cash ceiling test impairment charges, and Adjusted Net Income1 of $13.1 million, or $0.06 per diluted share; Recorded Adjusted EBITDA1 of $47.7 million; Incurred Lease Operating Expense (“LOE”) of $10.73 per Boe, 2% below the low end of recently lowered guidance due to ongoing efforts...

Direct Premiums Written Grow 14% and Net Income Increases 56% to $10.9 Million Management to Host Conference Call Tomorrow at 8:30 a.m. Eastern Time KINGSTON, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) — Kingstone Companies, Inc. (Nasdaq: KINS) (“Kingstone” or the “Company”), a Northeast regional property and casualty insurance holding company, today announced its financial results for the third quarter ended September 30, 2025. The Company has also provided an investor presentation that can be accessed through the News & Events/Presentations section of the Company website at www.kingstonecompanies.com.Key Financial and Operational Highlights              Quarters Ended Nine Months Ended  September 30, September 30,($ in thousands, except per share data)   2025     2024   Change   2025     2024   ChangeDirect premiums...

– GAAP LOSS PER COMMON SHARE FROM CONTINUING OPERATIONS OF $(0.13) –– DISTRIBUTABLE LOSS PER COMMON SHARE OF $(0.94) –– DISTRIBUTABLE LOSS PER COMMON SHARE BEFORE REALIZED LOSSES OF $(0.04) –       NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Ready Capital Corporation (“Ready Capital” or the “Company”) (NYSE: RC), a multi-strategy real estate finance company that originates, acquires, finances, and services lower-to-middle-market (“LMM”) investor and owner-occupied commercial real estate loans, today reported financial results for the quarter ended September 30, 2025. “Our primary focus continues to be restoring financial health,” said Thomas Capasse, Ready Capital’s Chairman and Chief Executive Officer. “Through our decisive exit strategies for our underperforming loan and real estate exposure...

First participant dosed in Phase 1 trial of BGE-102, oral CNS-penetrant NLRP3 inhibitor, with initial SAD data expected by year-end Continued advancement of oral and parenteral APJ agonist programs targeting 2026 IND submissions EMERYVILLE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today provided business updates and reported its third quarter 2025 financial results. “The third quarter of 2025 marked an important milestone as we advanced BGE-102 into clinical development with the dosing of our first participant in the Phase 1 trial,” said Kristen Fortney, PhD, CEO and co-founder of BioAge. “We’re on track to...

Quarter Sales of $203.8 million, up 62% from a year earlier, Quarter Net Income of $27.6 million, up 59% from a year earlier, Diluted EPS $1.20 for the Quarter, up 60% from a year earlier. WOOD DALE, Ill., Nov. 06, 2025 (GLOBE NEWSWIRE) — Power Solutions International, Inc. (the “Company” or “PSI”) (Nasdaq: PSIX), a leader in the design, engineering and manufacture of emission-certified engines and power systems, announced its record financial results for the third quarter 2025. Financial Highlights($ in millions, except per share amounts) Quarter Ended    September 30, 2025 September 30, 2024 ChangeNet Sales $203.8 $125.8 62%Gross Profit $48.7 $36.4 34%Net Income $27.6 $17.3 59%Diluted Earnings per Share $1.20 $0.75 $0.45Third Quarter 2025 Results PSI reported record net sales of $203.8 million and net income...

–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers – – Closed a private placement of up to $103 million in August 2025 to support advancement of SL-325 – – Appointments of Dan Baker, M.D., and Mona Ashiya, Ph.D. to the Board of Directors – AUSTIN, TX and DURHAM, NC, Nov. 06, 2025 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today reported financial results for the quarter ended September 30, 2025 and provided recent business highlights. “In the third quarter of 2025, SL-325 became the first DR3 blocking antibody to enter clinical development, and our Phase...